APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antifungal Drugs for Skin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antifungal Drugs for Skin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173966210327 December 2025193 pages

Choose your research edition.

Industry ResearchAntifungal Drugs for Skin Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Antifungal Drugs for Skin Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Antifungal Drugs for Skin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antifungal Drugs for Skin Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Antifungal Drugs for Skin Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Antifungal Drugs for Skin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antifungal Drugs for Skin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antifungal Drugs for Skin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antifungal Drugs for Skin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antifungal Drugs for Skin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antifungal Drugs for Skin include Aden Healthcare, AdvaCare Pharma, Amar Healthcare, AS lifesciences, Dr. Reddy's Laboratories, Pfizer, Shree Ganesh Remedies, Solisom Healthcare and Wellona Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antifungal Drugs for Skin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antifungal Drugs for Skin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antifungal Drugs for Skin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antifungal Drugs for Skin market size, projected growth trends, production technologies, key applications, and end-use industries.

Antifungal Drugs for Skin Segment by Company

Aden Healthcare

AdvaCare Pharma

Amar Healthcare

AS lifesciences

Dr. Reddy's Laboratories

Pfizer

Shree Ganesh Remedies

Solisom Healthcare

Wellona Pharma

Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.

Harbin Labton Pharmaceutical Co., Ltd.

Harbin Pharmaceutical Group Bioengineering Co., Ltd.

Hubei Hengan Fulin Pharmaceutical Co., Ltd.

Jiangsu Chenpai Pharmaceutical Group Co., Ltd.

Livzon Group Livzon Pharmaceutical Factory

Lunan Beite Pharmaceutical Co., Ltd.

Nanjing Chengong Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.

Shandong Chenxin Fodu Pharmaceutical Co., Ltd.

Shandong Fangming Pharmaceutical Group Co., Ltd.

Shanghai Baolong Pharmaceutical Co., Ltd.

Teyi Pharmaceutical Group Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Yunnan Longrun Pharmaceutical Co., Ltd.

Zhejiang East Asia Pharmaceutical Co., Ltd.

Antifungal Drugs for Skin Segment by Type

Amorolfine

Butenafine

Ciprofloxacin

Clotrimazole

Miconazole

Terbinafine

Ketoconazole

Econazole

Other

Antifungal Drugs for Skin Segment by Application

Hospital

Clinic

Other

Antifungal Drugs for Skin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antifungal Drugs for Skin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antifungal Drugs for Skin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antifungal Drugs for Skin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antifungal Drugs for Skin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antifungal Drugs for Skin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antifungal Drugs for Skin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antifungal Drugs for Skin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antifungal Drugs for Skin Industry Trends Table 2. Antifungal Drugs for Skin Industry Drivers Table 3. Antifungal Drugs for Skin Industry Opportunities and Challenges Table 4. Antifungal Drugs for Skin Industry Restraints Table 5. Global Antifungal Drugs for Skin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antifungal Drugs for Skin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antifungal Drugs for Skin Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Antifungal Drugs for Skin Sales Market Share by Manufacturers Table 9. Global Antifungal Drugs for Skin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Antifungal Drugs for Skin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antifungal Drugs for Skin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antifungal Drugs for Skin Manufacturers, Product Type & Application Table 13. Global Antifungal Drugs for Skin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antifungal Drugs for Skin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Amorolfine Table 17. Major Manufacturers of Butenafine Table 18. Major Manufacturers of Ciprofloxacin Table 19. Major Manufacturers of Clotrimazole Table 20. Major Manufacturers of Miconazole Table 21. Major Manufacturers of Terbinafine Table 22. Major Manufacturers of Ketoconazole Table 23. Major Manufacturers of Econazole Table 24. Major Manufacturers of Other Table 25. Global Antifungal Drugs for Skin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Antifungal Drugs for Skin Sales by Type (2021-2026) & (K Units) Table 27. Global Antifungal Drugs for Skin Sales by Type (2027-2032) & (K Units) Table 28. Global Antifungal Drugs for Skin Sales Market Share by Type (2021-2026) Table 29. Global Antifungal Drugs for Skin Sales Market Share by Type (2027-2032) Table 30. Global Antifungal Drugs for Skin Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 31. Global Antifungal Drugs for Skin Revenue by Type (2021-2026) & (K Units) Table 32. Global Antifungal Drugs for Skin Revenue by Type (2027-2032) & (K Units) Table 33. Global Antifungal Drugs for Skin Revenue Market Share by Type (2021-2026) Table 34. Global Antifungal Drugs for Skin Revenue Market Share by Type (2027-2032) Table 35. Major Manufacturers of Hospital Table 36. Major Manufacturers of Clinic Table 37. Major Manufacturers of Other Table 38. Global Antifungal Drugs for Skin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Antifungal Drugs for Skin Sales by Application (2021-2026) & (K Units) Table 40. Global Antifungal Drugs for Skin Sales by Application (2027-2032) & (K Units) Table 41. Global Antifungal Drugs for Skin Sales Market Share by Application (2021-2026) Table 42. Global Antifungal Drugs for Skin Sales Market Share by Application (2027-2032) Table 43. Global Antifungal Drugs for Skin Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 44. Global Antifungal Drugs for Skin Revenue by Application (2021-2026) & (K Units) Table 45. Global Antifungal Drugs for Skin Revenue by Application (2027-2032) & (K Units) Table 46. Global Antifungal Drugs for Skin Revenue Market Share by Application (2021-2026) Table 47. Global Antifungal Drugs for Skin Revenue Market Share by Application (2027-2032) Table 48. Global Antifungal Drugs for Skin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 49. Global Antifungal Drugs for Skin Sales by Region (2021-2026) & (K Units) Table 50. Global Antifungal Drugs for Skin Sales Market Share by Region (2021-2026) Table 51. Global Antifungal Drugs for Skin Sales Forecasted by Region (2027-2032) & (K Units) Table 52. Global Antifungal Drugs for Skin Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Antifungal Drugs for Skin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. North America Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 55. North America Antifungal Drugs for Skin Sales by Country (2027-2032) & (K Units) Table 56. Europe Antifungal Drugs for Skin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Europe Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 58. Europe Antifungal Drugs for Skin Sales by Country (2027-2032) & (K Units) Table 59. Asia Pacific Antifungal Drugs for Skin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Asia Pacific Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 61. Asia Pacific Antifungal Drugs for Skin Sales by Country (2027-2032) & (K Units) Table 62. South America, Middle East and Africa Antifungal Drugs for Skin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 63. South America, Middle East and Africa Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 64. South America, Middle East and Africa Antifungal Drugs for Skin Sales by Country (2027-2032) & (K Units) Table 65. Global Antifungal Drugs for Skin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Antifungal Drugs for Skin Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Antifungal Drugs for Skin Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Antifungal Drugs for Skin Revenue Market Share by Region (2021-2026) Table 69. Global Antifungal Drugs for Skin Revenue Market Share by Region (2027-2032) Table 70. Aden Healthcare Company Information Table 71. Aden Healthcare Business Overview Table 72. Aden Healthcare Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Aden Healthcare Antifungal Drugs for Skin Product Portfolio Table 74. Aden Healthcare Recent Development Table 75. AdvaCare Pharma Company Information Table 76. AdvaCare Pharma Business Overview Table 77. AdvaCare Pharma Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. AdvaCare Pharma Antifungal Drugs for Skin Product Portfolio Table 79. AdvaCare Pharma Recent Development Table 80. Amar Healthcare Company Information Table 81. Amar Healthcare Business Overview Table 82. Amar Healthcare Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Amar Healthcare Antifungal Drugs for Skin Product Portfolio Table 84. Amar Healthcare Recent Development Table 85. AS lifesciences Company Information Table 86. AS lifesciences Business Overview Table 87. AS lifesciences Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. AS lifesciences Antifungal Drugs for Skin Product Portfolio Table 89. AS lifesciences Recent Development Table 90. Dr. Reddy's Laboratories Company Information Table 91. Dr. Reddy's Laboratories Business Overview Table 92. Dr. Reddy's Laboratories Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Dr. Reddy's Laboratories Antifungal Drugs for Skin Product Portfolio Table 94. Dr. Reddy's Laboratories Recent Development Table 95. Pfizer Company Information Table 96. Pfizer Business Overview Table 97. Pfizer Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Pfizer Antifungal Drugs for Skin Product Portfolio Table 99. Pfizer Recent Development Table 100. Shree Ganesh Remedies Company Information Table 101. Shree Ganesh Remedies Business Overview Table 102. Shree Ganesh Remedies Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Shree Ganesh Remedies Antifungal Drugs for Skin Product Portfolio Table 104. Shree Ganesh Remedies Recent Development Table 105. Solisom Healthcare Company Information Table 106. Solisom Healthcare Business Overview Table 107. Solisom Healthcare Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Solisom Healthcare Antifungal Drugs for Skin Product Portfolio Table 109. Solisom Healthcare Recent Development Table 110. Wellona Pharma Company Information Table 111. Wellona Pharma Business Overview Table 112. Wellona Pharma Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Wellona Pharma Antifungal Drugs for Skin Product Portfolio Table 114. Wellona Pharma Recent Development Table 115. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Company Information Table 116. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Business Overview Table 117. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 119. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Recent Development Table 120. Harbin Labton Pharmaceutical Co., Ltd. Company Information Table 121. Harbin Labton Pharmaceutical Co., Ltd. Business Overview Table 122. Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 124. Harbin Labton Pharmaceutical Co., Ltd. Recent Development Table 125. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Company Information Table 126. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Business Overview Table 127. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 129. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Recent Development Table 130. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Company Information Table 131. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Business Overview Table 132. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 134. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Recent Development Table 135. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Company Information Table 136. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Business Overview Table 137. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 139. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Recent Development Table 140. Livzon Group Livzon Pharmaceutical Factory Company Information Table 141. Livzon Group Livzon Pharmaceutical Factory Business Overview Table 142. Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Product Portfolio Table 144. Livzon Group Livzon Pharmaceutical Factory Recent Development Table 145. Lunan Beite Pharmaceutical Co., Ltd. Company Information Table 146. Lunan Beite Pharmaceutical Co., Ltd. Business Overview Table 147. Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 149. Lunan Beite Pharmaceutical Co., Ltd. Recent Development Table 150. Nanjing Chengong Pharmaceutical Co., Ltd. Company Information Table 151. Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview Table 152. Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 154. Nanjing Chengong Pharmaceutical Co., Ltd. Recent Development Table 155. Qilu Pharmaceutical Co., Ltd. Company Information Table 156. Qilu Pharmaceutical Co., Ltd. Business Overview Table 157. Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 159. Qilu Pharmaceutical Co., Ltd. Recent Development Table 160. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information Table 161. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview Table 162. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 164. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Development Table 165. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information Table 166. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview Table 167. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 169. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Development Table 170. Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information Table 171. Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview Table 172. Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 174. Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Development Table 175. Shanghai Baolong Pharmaceutical Co., Ltd. Company Information Table 176. Shanghai Baolong Pharmaceutical Co., Ltd. Business Overview Table 177. Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 178. Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 179. Shanghai Baolong Pharmaceutical Co., Ltd. Recent Development Table 180. Teyi Pharmaceutical Group Co., Ltd. Company Information Table 181. Teyi Pharmaceutical Group Co., Ltd. Business Overview Table 182. Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 183. Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 184. Teyi Pharmaceutical Group Co., Ltd. Recent Development Table 185. Southwest Pharmaceutical Co., Ltd. Company Information Table 186. Southwest Pharmaceutical Co., Ltd. Business Overview Table 187. Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 188. Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 189. Southwest Pharmaceutical Co., Ltd. Recent Development Table 190. Yunnan Longrun Pharmaceutical Co., Ltd. Company Information Table 191. Yunnan Longrun Pharmaceutical Co., Ltd. Business Overview Table 192. Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 193. Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 194. Yunnan Longrun Pharmaceutical Co., Ltd. Recent Development Table 195. Zhejiang East Asia Pharmaceutical Co., Ltd. Company Information Table 196. Zhejiang East Asia Pharmaceutical Co., Ltd. Business Overview Table 197. Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 198. Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 199. Zhejiang East Asia Pharmaceutical Co., Ltd. Recent Development Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Antifungal Drugs for Skin Distributors List Table 203. Antifungal Drugs for Skin Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Antifungal Drugs for Skin Product Image Figure 2. Global Antifungal Drugs for Skin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antifungal Drugs for Skin Market Size (2021-2032) & (US$ Million) Figure 4. Global Antifungal Drugs for Skin Sales (2021-2032) & (K Units) Figure 5. Global Antifungal Drugs for Skin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antifungal Drugs for Skin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Amorolfine Image Figure 9. Butenafine Image Figure 10. Ciprofloxacin Image Figure 11. Clotrimazole Image Figure 12. Miconazole Image Figure 13. Terbinafine Image Figure 14. Ketoconazole Image Figure 15. Econazole Image Figure 16. Other Image Figure 17. Global Antifungal Drugs for Skin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Antifungal Drugs for Skin Sales Market Share 2021 VS 2025 VS 2032 Figure 19. Global Antifungal Drugs for Skin Sales Market Share by Type (2021-2032) Figure 20. Global Antifungal Drugs for Skin Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Antifungal Drugs for Skin Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Antifungal Drugs for Skin Revenue Market Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Clinic Image Figure 25. Other Image Figure 26. Global Antifungal Drugs for Skin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Antifungal Drugs for Skin Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Antifungal Drugs for Skin Sales Market Share by Application (2021-2032) Figure 29. Global Antifungal Drugs for Skin Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Antifungal Drugs for Skin Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Antifungal Drugs for Skin Revenue Market Share by Application (2021-2032) Figure 32. North America Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 33. North America Antifungal Drugs for Skin Sales Market Share by Country (2021-2032) Figure 34. U.S. Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Canada Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Mexico Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Europe Antifungal Drugs for Skin Sales Market Share by Country (2021-2032) Figure 39. Germany Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 40. France Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 41. U.K. Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Italy Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Netherlands Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Asia Pacific Antifungal Drugs for Skin Sales Market Share by Country (2021-2032) Figure 46. China Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Japan Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Korea Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Southeast Asia Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 50. India Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Australia Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South America, Middle East and Africa Antifungal Drugs for Skin Sales Market Share by Country (2021-2032) Figure 54. Brazil Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 55. South Africa Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Saudi Arabia Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Turkey Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Argentina Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 59. UAE Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Egypt Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Chile Antifungal Drugs for Skin Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Global Antifungal Drugs for Skin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Antifungal Drugs for Skin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Antifungal Drugs for Skin Revenue (2021-2032) & (US$ Million) Figure 65. North America Antifungal Drugs for Skin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Antifungal Drugs for Skin Revenue (2021-2032) & (US$ Million) Figure 67. Europe Antifungal Drugs for Skin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Antifungal Drugs for Skin Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Antifungal Drugs for Skin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Antifungal Drugs for Skin Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Antifungal Drugs for Skin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Antifungal Drugs for Skin Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Antifungal Drugs for Skin Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Amorolfine
  • Butenafine
  • Ciprofloxacin
  • Clotrimazole
  • Miconazole
  • Terbinafine
  • Ketoconazole
  • Econazole
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Aden Healthcare
  • AdvaCare Pharma
  • Amar Healthcare
  • AS lifesciences
  • Dr. Reddy's Laboratories
  • Pfizer
  • Shree Ganesh Remedies
  • Solisom Healthcare
  • Wellona Pharma
  • Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
  • Harbin Labton Pharmaceutical Co., Ltd.
  • Harbin Pharmaceutical Group Bioengineering Co., Ltd.
  • Hubei Hengan Fulin Pharmaceutical Co., Ltd.
  • Jiangsu Chenpai Pharmaceutical Group Co., Ltd.
  • Livzon Group Livzon Pharmaceutical Factory
  • Lunan Beite Pharmaceutical Co., Ltd.
  • Nanjing Chengong Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  • Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  • Shandong Fangming Pharmaceutical Group Co., Ltd.
  • Shanghai Baolong Pharmaceutical Co., Ltd.
  • Teyi Pharmaceutical Group Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Yunnan Longrun Pharmaceutical Co., Ltd.
  • Zhejiang East Asia Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antifungal Drugs for Skin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antifungal Drugs for Skin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antifungal Drugs for Skin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antifungal Drugs for Skin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antifungal Drugs for Skin Market Dynamics
  1. 2.1 Antifungal Drugs for Skin Industry Trends
  2. 2.2 Antifungal Drugs for Skin Industry Drivers
  3. 2.3 Antifungal Drugs for Skin Industry Opportunities and Challenges
  4. 2.4 Antifungal Drugs for Skin Industry Restraints
3 Antifungal Drugs for Skin Market by Manufacturers
  1. 3.1 Global Antifungal Drugs for Skin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antifungal Drugs for Skin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antifungal Drugs for Skin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antifungal Drugs for Skin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antifungal Drugs for Skin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antifungal Drugs for Skin Manufacturers, Product Type & Application
  7. 3.7 Global Antifungal Drugs for Skin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antifungal Drugs for Skin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antifungal Drugs for Skin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antifungal Drugs for Skin Tier 1, Tier 2, and Tier 3
4 Antifungal Drugs for Skin Market by Type
  1. 4.1 Antifungal Drugs for Skin Type Introduction
  2. 4.1.1 Amorolfine
  3. 4.1.2 Butenafine
  4. 4.1.3 Ciprofloxacin
  5. 4.1.4 Clotrimazole
  6. 4.1.5 Miconazole
  7. 4.1.6 Terbinafine
  8. 4.1.7 Ketoconazole
  9. 4.1.8 Econazole
  10. 4.1.9 Other
  11. 4.2 Global Antifungal Drugs for Skin Sales by Type
  12. 4.2.1 Global Antifungal Drugs for Skin Sales by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Antifungal Drugs for Skin Sales by Type (2021-2032)
  14. 4.2.3 Global Antifungal Drugs for Skin Sales Market Share by Type (2021-2032)
  15. 4.3 Global Antifungal Drugs for Skin Revenue by Type
  16. 4.3.1 Global Antifungal Drugs for Skin Revenue by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global Antifungal Drugs for Skin Revenue by Type (2021-2032)
  18. 4.3.3 Global Antifungal Drugs for Skin Revenue Market Share by Type (2021-2032)
5 Antifungal Drugs for Skin Market by Application
  1. 5.1 Antifungal Drugs for Skin Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Antifungal Drugs for Skin Sales by Application
  6. 5.2.1 Global Antifungal Drugs for Skin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antifungal Drugs for Skin Sales by Application (2021-2032)
  8. 5.2.3 Global Antifungal Drugs for Skin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Antifungal Drugs for Skin Revenue by Application
  10. 5.3.1 Global Antifungal Drugs for Skin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Antifungal Drugs for Skin Revenue by Application (2021-2032)
  12. 5.3.3 Global Antifungal Drugs for Skin Revenue Market Share by Application (2021-2032)
6 Global Antifungal Drugs for Skin Sales by Region
  1. 6.1 Global Antifungal Drugs for Skin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antifungal Drugs for Skin Sales by Region (2021-2032)
  3. 6.2.1 Global Antifungal Drugs for Skin Sales by Region (2021-2026)
  4. 6.2.2 Global Antifungal Drugs for Skin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antifungal Drugs for Skin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antifungal Drugs for Skin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antifungal Drugs for Skin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antifungal Drugs for Skin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antifungal Drugs for Skin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antifungal Drugs for Skin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antifungal Drugs for Skin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antifungal Drugs for Skin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antifungal Drugs for Skin Revenue by Region
  1. 7.1 Global Antifungal Drugs for Skin Revenue by Region
  2. 7.1.1 Global Antifungal Drugs for Skin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antifungal Drugs for Skin Revenue by Region (2021-2026)
  4. 7.1.3 Global Antifungal Drugs for Skin Revenue by Region (2027-2032)
  5. 7.1.4 Global Antifungal Drugs for Skin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antifungal Drugs for Skin Revenue (2021-2032)
  8. 7.2.2 North America Antifungal Drugs for Skin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antifungal Drugs for Skin Revenue (2021-2032)
  11. 7.3.2 Europe Antifungal Drugs for Skin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antifungal Drugs for Skin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antifungal Drugs for Skin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antifungal Drugs for Skin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antifungal Drugs for Skin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aden Healthcare
  2. 8.1.1 Aden Healthcare Company Information
  3. 8.1.2 Aden Healthcare Business Overview
  4. 8.1.3 Aden Healthcare Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aden Healthcare Antifungal Drugs for Skin Product Portfolio
  6. 8.1.5 Aden Healthcare Recent Developments
  7. 8.2 AdvaCare Pharma
  8. 8.2.1 AdvaCare Pharma Company Information
  9. 8.2.2 AdvaCare Pharma Business Overview
  10. 8.2.3 AdvaCare Pharma Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AdvaCare Pharma Antifungal Drugs for Skin Product Portfolio
  12. 8.2.5 AdvaCare Pharma Recent Developments
  13. 8.3 Amar Healthcare
  14. 8.3.1 Amar Healthcare Company Information
  15. 8.3.2 Amar Healthcare Business Overview
  16. 8.3.3 Amar Healthcare Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amar Healthcare Antifungal Drugs for Skin Product Portfolio
  18. 8.3.5 Amar Healthcare Recent Developments
  19. 8.4 AS lifesciences
  20. 8.4.1 AS lifesciences Company Information
  21. 8.4.2 AS lifesciences Business Overview
  22. 8.4.3 AS lifesciences Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AS lifesciences Antifungal Drugs for Skin Product Portfolio
  24. 8.4.5 AS lifesciences Recent Developments
  25. 8.5 Dr. Reddy's Laboratories
  26. 8.5.1 Dr. Reddy's Laboratories Company Information
  27. 8.5.2 Dr. Reddy's Laboratories Business Overview
  28. 8.5.3 Dr. Reddy's Laboratories Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dr. Reddy's Laboratories Antifungal Drugs for Skin Product Portfolio
  30. 8.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Antifungal Drugs for Skin Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Shree Ganesh Remedies
  38. 8.7.1 Shree Ganesh Remedies Company Information
  39. 8.7.2 Shree Ganesh Remedies Business Overview
  40. 8.7.3 Shree Ganesh Remedies Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shree Ganesh Remedies Antifungal Drugs for Skin Product Portfolio
  42. 8.7.5 Shree Ganesh Remedies Recent Developments
  43. 8.8 Solisom Healthcare
  44. 8.8.1 Solisom Healthcare Company Information
  45. 8.8.2 Solisom Healthcare Business Overview
  46. 8.8.3 Solisom Healthcare Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Solisom Healthcare Antifungal Drugs for Skin Product Portfolio
  48. 8.8.5 Solisom Healthcare Recent Developments
  49. 8.9 Wellona Pharma
  50. 8.9.1 Wellona Pharma Company Information
  51. 8.9.2 Wellona Pharma Business Overview
  52. 8.9.3 Wellona Pharma Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Wellona Pharma Antifungal Drugs for Skin Product Portfolio
  54. 8.9.5 Wellona Pharma Recent Developments
  55. 8.10 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
  56. 8.10.1 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  60. 8.10.5 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Harbin Labton Pharmaceutical Co., Ltd.
  62. 8.11.1 Harbin Labton Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Harbin Labton Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  66. 8.11.5 Harbin Labton Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Harbin Pharmaceutical Group Bioengineering Co., Ltd.
  68. 8.12.1 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Company Information
  69. 8.12.2 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Business Overview
  70. 8.12.3 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  72. 8.12.5 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Recent Developments
  73. 8.13 Hubei Hengan Fulin Pharmaceutical Co., Ltd.
  74. 8.13.1 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  78. 8.13.5 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Jiangsu Chenpai Pharmaceutical Group Co., Ltd.
  80. 8.14.1 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Company Information
  81. 8.14.2 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Business Overview
  82. 8.14.3 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  84. 8.14.5 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Recent Developments
  85. 8.15 Livzon Group Livzon Pharmaceutical Factory
  86. 8.15.1 Livzon Group Livzon Pharmaceutical Factory Company Information
  87. 8.15.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
  88. 8.15.3 Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Product Portfolio
  90. 8.15.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
  91. 8.16 Lunan Beite Pharmaceutical Co., Ltd.
  92. 8.16.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Lunan Beite Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  96. 8.16.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Nanjing Chengong Pharmaceutical Co., Ltd.
  98. 8.17.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  102. 8.17.5 Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Qilu Pharmaceutical Co., Ltd.
  104. 8.18.1 Qilu Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  108. 8.18.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  110. 8.19.1 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  114. 8.19.5 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  116. 8.20.1 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information
  117. 8.20.2 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview
  118. 8.20.3 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  120. 8.20.5 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Developments
  121. 8.21 Shandong Fangming Pharmaceutical Group Co., Ltd.
  122. 8.21.1 Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information
  123. 8.21.2 Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview
  124. 8.21.3 Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  126. 8.21.5 Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Developments
  127. 8.22 Shanghai Baolong Pharmaceutical Co., Ltd.
  128. 8.22.1 Shanghai Baolong Pharmaceutical Co., Ltd. Company Information
  129. 8.22.2 Shanghai Baolong Pharmaceutical Co., Ltd. Business Overview
  130. 8.22.3 Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  132. 8.22.5 Shanghai Baolong Pharmaceutical Co., Ltd. Recent Developments
  133. 8.23 Teyi Pharmaceutical Group Co., Ltd.
  134. 8.23.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
  135. 8.23.2 Teyi Pharmaceutical Group Co., Ltd. Business Overview
  136. 8.23.3 Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  138. 8.23.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments
  139. 8.24 Southwest Pharmaceutical Co., Ltd.
  140. 8.24.1 Southwest Pharmaceutical Co., Ltd. Company Information
  141. 8.24.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  142. 8.24.3 Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  144. 8.24.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  145. 8.25 Yunnan Longrun Pharmaceutical Co., Ltd.
  146. 8.25.1 Yunnan Longrun Pharmaceutical Co., Ltd. Company Information
  147. 8.25.2 Yunnan Longrun Pharmaceutical Co., Ltd. Business Overview
  148. 8.25.3 Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  150. 8.25.5 Yunnan Longrun Pharmaceutical Co., Ltd. Recent Developments
  151. 8.26 Zhejiang East Asia Pharmaceutical Co., Ltd.
  152. 8.26.1 Zhejiang East Asia Pharmaceutical Co., Ltd. Company Information
  153. 8.26.2 Zhejiang East Asia Pharmaceutical Co., Ltd. Business Overview
  154. 8.26.3 Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  156. 8.26.5 Zhejiang East Asia Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antifungal Drugs for Skin Value Chain Analysis
  2. 9.1.1 Antifungal Drugs for Skin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antifungal Drugs for Skin Production Mode & Process
  6. 9.2 Antifungal Drugs for Skin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antifungal Drugs for Skin Distributors
  9. 9.2.3 Antifungal Drugs for Skin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst